Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, September 15, 2017
SCA Pharmaceuticals announced the appointment of Milton Boyer as Chief Executive Officer.
read more
Monday, December 04, 2017
SCA Pharmaceuticals celebrated the official opening of its 90,000 square foot manufacturing facility on November 27th, 2017.
read more
Monday, December 03, 2018
Scientist.com and Allele have partnered to develop nanoantibodies for therapeutic applications.
read more
UK-based sterile manufacturing specialist SCM Pharma has bolstered its North American profile with the appointment of a US-based business development manager.
read more
Wednesday, April 27, 2022
Biopharmaceutical contract development and manufacturing organization (CDMO) Scorpion Biological Services (Scorpion) today announced a planned development partnership with a private developer, the State of Kansas, and local and university affiliates,...
read more
Scorpion Biological Services (Scorpion), a biopharmaceutical contract development and manufacturing organization (CDMO) and contract research organization (CRO), today announced the appointment of Stephan Kutzer, Ph.D. as its Interim Chief Executive ...
read more
Tuesday, December 20, 2022
Scorpion Biological Services has changed its name to Scorpius BioManufacturing to reflect the company’s recently expanded manufacturing capabilities and the grand opening of its new biomanufacturing facility in San Antonio in October.
read more
Pharmaceutical and biopharmaceutical companies that outsource manufacturing see their relationship with manufacturers differently than do CDMOs and CMOs.
read more
Thursday, February 18, 2021
SCYNEXIS has entered into a licensing agreement and strategic partnership with Hansoh Pharmaceutical Group.
read more
Sekisui Diagnostics Enzyme business announces the completion of a new BioProcess Innovation Centre at the site in Maidstone, Kent by the end of 2019, following a $1.9 million investment.
read more
Wednesday, January 09, 2019
Selexis has signed additional CLAs with Agenus, an immuno-oncology company with a pipeline of immune-modulating antibodies, cancer vaccines, and adoptive cell therapies.
read more
Seneca Biopharma announced the completion of its new cell manufacturing facility in Suzhou, China.
read more
Tuesday, November 08, 2011
Sentinel Capital Partners, a private equity firm that invests in promising lower middle market companies, today announced its acquisition of WellSpring Pharmaceutical Corporation, a North American manufacturer and marketer of specialty prescription ...
read more
Wednesday, September 22, 2021
Seqens CDMO, a pharmaceutical manufacturer of new chemical entities (NCEs), active pharmaceutical ingredients (APIs) and other specialty chemical products, announced that Bob Huang has joined as Managing Director for North America. The company is a ...
read more
Tuesday, September 22, 2020
Seqens CDMO North America has appointed Jean-Noel David as Managing Director for North America.
read more